Information Incorporated by Reference Sample Clauses

Information Incorporated by Reference. To the extent that information is incorporated by reference into any Preliminary Prospectus, the Commitment Prospectus, the Prospectus, or the Registration Statement pursuant to the rules and regulations of the Commission, the terms "Preliminary Prospectus," "Commitment Prospectus," "Prospectus," and "Registration Statement," as the case may be, shall be deemed to include the information so incorporated. Please confirm that the foregoing correctly sets forth the agreement among the Company and the several Underwriters. Very truly yours, Xxxx.xxx, Inc. President and Chief Executive Officer Solely with respect to Sections 5.2, 6.2, 8, 9, 13, 16, 18, and 20 of this Agreement, the Selling Stockholders named in Section II hereto, acting Severally By: attorney-in-fact CONFIRMED as of the date first above mentioned, on behalf of the Representative and the other several Underwriters named in Schedule I hereto. ThinkEquity Partners, LLC By: [Authorized Representative] 37 SCHEDULE I Name Number Firm Shares ThinkEquity Partners, LLC Pacific Growth Equities, LLC Susquehanna Financial Group, LLLP Total SCHEDULE III Name Number Firm Shares Total SCHEDULE II Pricing Disclosure Package QuickLinks Exhibit 1
Information Incorporated by Reference. The following information shall be deemed to be incorporated in, and to form part of, this Base Prospectus:
Information Incorporated by Reference. Enterprise Parent files annual, quarterly and current reports, and other information with the Commission under the Exchange Act (Commission File No. 1-14323). You may read and copy any document Enterprise Parent files at the Commission’s public reference room at 100 X Xxxxxx, X.X., Xxxxxxxxxx, X.X. 00000. Please call the Commission at 1-800-732-0330 for further information on the public reference room. Enterprise Parent’s filings are also available to the public at the Commission’s web site at hxxx://xxx.xxx.xxx. In addition, documents filed by Enterprise Parent can be inspected at the offices of the New York Stock Exchange, Inc. 20 Xxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000. Enterprise Parent hereby incorporates by reference the documents listed below and any future filings it makes with the Commission under section 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934 until this offering is completed (other than information furnished under Items 2.02 or 7.01 of any Form 8-K, which is not deemed filed under the Exchange Act): • Annual Report on Form 10-K for the year ended December 31, 2005; • Quarterly Reports on Form 10-Q for the periods ended March 31, 2006 and June 30, 2006; and • Current Reports on Form 8-K filed with the Commission on February 16, 2006, February 17, 2006, February 27, 2006, March 3, 2006, June 26, 2006, June 26, 2006, July 13, 2006, July 19, 2006, August 14, 2006, August 25, 2006 and September 8, 2006. FORWARD-LOOKING STATEMENTS This document and some of the documents we have incorporated herein by reference contain various forward-looking statements and information that are based on our beliefs and those of our general partner, as well as assumptions made by and information currently available to us. These forward- looking statements are identified as any statement that does not relate strictly to historical or current facts. When used in this document or the documents we have incorporated herein by reference, words such as “anticipate,” “project,” “expect,” “plan,” “goal,” “forecast,” “intend,” “could,” “believe,” “may,” and similar expressions and statements regarding our plans and objectives for future operations, are intended to identify forward-looking statements. Although we and our general partner believe that such expectations reflected in such forward-looking statements are reasonable, neither we nor our general partner can give assurances that such expectations will prove to be correct. Such statements are subject ...
Information Incorporated by Reference. The audited consolidated financial statements (including the auditors' report thereon and notes thereto) of TICO in respect of the years ended 31 March 2007 and 31 March 2008 (set out on pages 74 to 97 of the TICO Annual Report 2008) (the "TICO 2007/2008 Financial Statements") shall be deemed to be incorporated in, and to form part of, this Prospectus. Copies of the TICO 2007/2008 Financial Statements may be inspected, free of charge, at the business addresses of TICO, 0-0 Xxxxxx-xxx, Xxxxxx-xxx, Aichi 448-8671 Japan, and are also available on TICO's website, xxx.xxxxxx-xxxxxxxxxx.xxx. The TICO 2007/2008 Financial Statements are prepared and presented in accordance with Japanese generally accepted accounting principles and material differences exist between Japanese generally accepted accounting principles and International Financial Reporting Standards which might be material to the financial information herein. Prospective investors should perform their own analysis if such differences are important to their investment decision. Any information contained in any of the documents specified above which is not incorporated by reference in this Prospectus is either not relevant to investors or is covered elsewhere in this Prospectus.
Information Incorporated by Reference. In addition to those documents set forth under the heading Information Incorporated By Reference in the accompanying prospectus, we also incorporate by reference herein our proxy statement for our Annual Meeting of Stockholders held on June 19, 2001. FORWARD-LOOKING STATEMENTS
Information Incorporated by Reference. The pages set out in the “Table of documents incorporated by reference” below which are extracted from the following documents shall be deemed to be incorporated in, and to form part of, this Prospectus: (a) the audited consolidated financial statements of the Issuer prepared in accordance with the International Financial Reporting Standards as adopted by the EU (“IFRS”) as at and for the financial year ended 31 December 2014 (the “2014 IFRS Consolidated Financial Statements”); (b) the audited consolidated financial statements of the Issuer prepared in accordance with IFRS as at and for the financial year ended 31 December 2013 (the “2013 IFRS Consolidated Financial Statements”) together in each case with the auditor’s report stated therein; and (c) the unaudited condensed interim consolidated financial statements of the Issuer prepared in accordance with IFRS as at and for the three-month period ended on 31 March 2015 (the “Q1 2015 IFRS Condensed Interim Consolidated Financial Statements”). Such documents are incorporated into, and form part of, this Prospectus, save that: (a) any statement contained therein shall be modified or superseded for the purpose of this Prospectus to the extent that a statement herein modifies or supersedes such earlier statement (whether expressly, by implication or otherwise); and (b) any information contained in the aforementioned annual financial statements, but not included in the cross-reference tables set out below, is not incorporated by reference in this Prospectus because such information is either not relevant for investors or is covered elsewhere in this Prospectus.
Information Incorporated by Reference. The Securities and Exchange Commission allows Cytogen to "incorporate by reference" the information Cytogen files with the Securities and Exchange Commission, which means that Cytogen can disclose important information to you by referring you to those documents. The information incorporated by reference is an important part of this prospectus, and information that Cytogen files later with the Securities and Exchange Commission will automatically update and supersede this information. Cytogen incorporates by reference the documents listed below and any future filings made by Cytogen with the Securities and Exchange Commission under Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, until the filing of a post-effective amendment to this prospectus which indicates that all securities registered have been sold or which deregisters all securities then remaining unsold: o The description of our common stock contained in each of Exhibit 3.1 to our Form 10-Q Quarterly Report for the quarter ended June 30, 2000 and Exhibit 3 to our Form 10-Q Quarterly Report for the quarter ended June 30, 1996; o The description of our Series C Junior Participating Preferred Stock contained in Exhibit 1 to our Current Report on Form 8-K filed with the Securities and Exchange Commission on June 24, 1998; o Cytogen's Annual Report on Form 10-K for the year ended December 31, 2000 filed with the Securities and Exchange Commission on March 30, 2001; o All other reports filed by Cytogen pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, since December 31, 2000; o The description of our common stock contained in our Registration Statement on Form 8-A; and o The description of our preferred stock contained in our Registration Statement on Form 8-A. Cytogen will provide to any person, including any beneficial owner of its securities, to whom this Prospectus is delivered, a copy of any or all of the information that has been incorporated by reference in this Prospectus but not delivered with this Prospectus. You may make such requests at no cost to you by writing or telephoning Cytogen at the following address or number: Cytogen Corporation 600 College Road East Princeton, New Xxxxxx 00000 Xxxxxxxxx: Xxxxxxx Xxxxxxx Telephone: (609) 750-8220 You should rely only on the information incorpxxxxxx xx xxxxrence or provided in this Prospectus or any Prospectus Supplement. Cytogen has not authorized anyone else to provide you ...